Full-Year Revenue and EPS Growth
Revenue for fiscal 2025 was $2.09B, up ~13.6% year-over-year; adjusted EPS grew 18% to $1.95, reflecting sustained double-digit growth and strong margin conversion.
Quarterly Revenue and EPS Beat
Q4 2025 revenue was $542.6M, up 12.6% organic constant currency year-over-year; Q4 adjusted EPS was $0.50, up 15% year-over-year, and both revenue and EPS exceeded expectations.
Data & AI Momentum
Data and AI-led revenue grew ~21% year-over-year and now represents 57% of total revenue; full-year data & AI-led growth was ~18% — validating the company's pivot to AI-led services.
Operations and Segment Strength
Total operations grew 11% in Q4 and 14% full-year; Healthcare & Life Sciences was the fastest-growing segment at ~26% YoY in Q4, Banking grew ~11% YoY, Insurance grew ~7% YoY, and International grew ~8% YoY.
Major Client Wins and Deal Momentum
Q4 dollar volume of wins was more than double any other quarter in 2025, including a new enterprise transformation engagement with a large North American insurer, a major expansion with a top-five healthcare payer, and significant renewals/expansions in financial services and fintech.
Partnerships, IP and Market Recognition
Strengthened partner ecosystem with AWS, Databricks, Google, Microsoft, NVIDIA, Genesys; 16 solutions on partner marketplaces; named Google Cloud strategic services partner and AWS 2025 AIML Market Disruptor of the Year; awarded 10 new U.S. patents in the past 12 months.
Recurring Revenue and Pipeline Visibility
More than 75% of revenue is recurring or annuity-like, management reports excellent visibility into 2026 with a robust pipeline and strong Q4 momentum leading into the year.
Capital Allocation Actions
Board authorized a new $500M stock repurchase program (two years); company repurchased ~7.5M shares in 2025 for $317M; cash & investments were $331M with a net cash position of $32M (after $299M revolver), signaling shareholder returns priority.
2026 Financial Outlook
Guidance for 2026: revenue of $2.275B–$2.315B (9%–11% organic constant-currency growth) and adjusted diluted EPS of $2.14–$2.19 (10%–12% growth), with capex expected at $50M–$55M and full-year effective tax rate 21%–22%.